R1

Divarasib Raises the KRAS G12C Bar

Mango research exposes the limits of judging food by sugar alone

Firefighter cardiac screening may be looking too narrowly at coronary disease

Menopause before 40 should not be treated as a reproductive footnote

Low testosterone in young men may be a metabolic warning sign, not a treatment target

AstraZeneca’s potential $1.5B insitro deal puts AI on the hardest question in cardiometabolic R&D

Severe preeclampsia may leave a measurable signature in the fetal heart

One Blood Test for 50 Cancers Is Closer to the FDA. The Evidence Is Still Fighting Back.

Schizophrenia Gets a Five-Day Brain-Stimulation Signal
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
